Health Letter, December 2022
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
Atenolol tablets, 25 mg, 1,000-count bottle. Manufactured by: ALPHAPHARM PTY LTD. Lot #: GS046745, exp. date: 12/2023.
Buprenorphine and naloxone sublingual tablets, 8 mg/2 mg, 30-count bottles. Distributed by: Sun Pharmaceutical Industries, Inc. Manufactured by: Sun Pharmaceutical Industries Ltd. Lot #: DNC1129A, exp. date: 06/2023; Lot #: DNC1740A, exp. date: 09/2023.
Quinapril and hydrochlorothiazide tablets, 20mg/12.5mg, 90-count bottles. Distributed by: Aurobindo Pharma USA, Inc. Lot #: QE2021005-A or QE2021010-A, exp. date: 01/2023.
Rifampin capsules; 150 or 300 mg; 30-, 60- or 100-count bottles. Manufactured by Patheon Pharmaceuticals Inc. Lot #: GS041430 or GS041941, exp. date: 1/31/2023; Lot #: GS041315, GS042991, GS043027, GS043367, GS043501 or GS044421, exp. date: 3/31/2023; Lot #: GS041431, GS041799, GS042287, GS042414 or GS042879, exp. date: 1/31/2023; Lot #: GS041316, GS042992, GS043368 or GS043579, exp. date: 3/31/2023; Lot #: GS041429 or GS041877, exp. date: 1/31/2023; Lot #: GS041317, GS043028, GS043366 or GS044422, exp. date: 3/31/2023; Lot #: GS036715, GS037569, GS038132, GS038665, GS038750, GS039565, GS039997 or GS040673, exp. date: 10/31/2022; Lot #: GS040674, GS041237, GS041652, GS042152 or GS043365, exp. date: 3/31/2023; Lot #: GS045441, GS045677 or GS046111, exp. date: 2/29/2024.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.